Tissue Engineering Market Scope and Key Players Analysis by 2028
Tissue Engineering Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 13.24 Billion |
| Market Size by 2028 | US$ 29.66 Billion |
| Global CAGR (2022 - 2028) | 12.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Material Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Tissue engineering – Market Segmentation
The global tissue engineering market is analyzed on the basis of material type and application. Based on material type, the market is further segmented into synthetic material, biologically derived materials, and others. Based on application, the market is segmented into orthopedic, musculoskeletal & spine, neurology, cardiology & vascular, skin & integumentary, urology, GI & gynecology, cancer, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of SAM).
Company Profiles
- Stryker Corporation
- Organogenesis Inc.
- Cook Biotech Inc.
- Integra Life Sciences Corporation
- 3M
- AbbVie Inc.
- Medtronic
- Zimmer Biomet
- Baxter International Inc.
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- B. Braun Melsungen AG
Get Free Sample For